Hvad betyder "Ryd"?
Dyret bærer ikke mutationen. Det vil ikke udvikle sygdommen og vil ikke give det videre.
Hund Medfødt myastenisk syndrom hos Heideterrier (CMS-H)
Discover the importance of the DNA test for Congenital Myasthenic Syndrome (CMS) in Heideterriers, a hereditary neuromuscular disorder affecting this unique dog breed. Early genetic screening helps breeders identify carriers and prevent the transmission of CMS, ensuring healthier litters. This precise DNA test detects mutations linked to CMS, allowing for informed breeding decisions and improved canine health. Regular testing supports responsible breeding practices and enhances the overall well-being of Heideterriers. Protect your dog’s future by choosing reliable CMS DNA testing today. Stay proactive in managing congenital health risks with advanced genetic tools.
Forkortelse: CMS-H
Analyseret mutation: CHRNE c.1436_1437insG
Arv: Autosomal recessiv
Akronym
CMS-H
Observeret frekvens
Klinisk sværhedsgrad
Klinisk klassificering
Neuromuskulære sygdomme
Analyseret mutation
CHRNE c.1436_1437insG
p.(S503Rfs*14)
p.(S503Rfs*14)
Arvemåde
Autosomal recessiv
Testresumé:
The DNA test for Congenital Myasthenic Syndrome (CMS) in Heideterriers helps identify genetic mutations responsible for this inherited neuromuscular disorder. CMS causes muscle weakness and fatigue due to impaired nerve-to-muscle communication. Early detection through genetic testing enables breeders to make informed decisions and reduce the risk of passing the condition to offspring. This test is essential for maintaining the health and vitality of the Heideterrier breed. Regular screening supports responsible breeding and improves overall canine welfare.
Tilgængelig fra pakken: Basic
Denne DNA-test er inkluderet fra vores pakke Basic — og er også en del af pakkerne Basic, Standard, Advanced, Complete.
Se DNA-testpakker →Vælg den flok, der passer bedst til din avls- eller sundhedsstrategi for dine dyr.
Overview of Congenital Myasthenic Syndrome (CMS)
Congenital Myasthenic Syndrome (CMS) is a group of inherited neuromuscular disorders characterized by weakness and fatigue of voluntary muscles. This condition results from defects in the transmission of nerve impulses to muscles, leading to compromised muscle function. It is caused by genetic mutations that affect the proteins responsible for neuromuscular transmission, notably at the neuromuscular junction where nerve cells communicate with muscles.
Symptoms of CMS in Dogs
Dogs affected by CMS may exhibit a range of symptoms, including muscle weakness, exercise intolerance, and fatigue. Some dogs may also show signs of difficulty in swallowing, facial muscle weakness, and a tendency to collapse after exertion. These symptoms can vary in severity and may be mistaken for other conditions, making a proper diagnosis crucial for effective management.
Importance of DNA Testing for CMS
DNA testing plays a vital role in identifying genetic mutations associated with Congenital Myasthenic Syndrome. By analyzing specific genes known to be linked to CMS, veterinarians and breeders can better understand the genetic predisposition of individual dogs. This information is crucial for making informed breeding decisions and helps in managing the condition in affected dogs.
Ledelses- og behandlingsmuligheder
Currently, there is no cure for Congenital Myasthenic Syndrome; however, management strategies are available to improve the quality of life for affected dogs. Treatment often includes the use of medications such as anticholinesterase agents, which can enhance neuromuscular transmission. Supportive care, including physical therapy and nutritional management, is also essential to help maintain muscle function and overall health.
Konklusion
Congenital Myasthenic Syndrome is a serious condition that can significantly affect the life of a dog. Early diagnosis through DNA testing can facilitate proper management and care, ensuring that affected dogs receive the support they need to lead a fulfilling life. Understanding the implications of this condition is vital for dog owners, breeders, and veterinary professionals alike.
Racen anerkendt til testen: Medfødt myastenisk syndrom hos Heideterrier (CMS-H)
- Heideterrier
- Smooth Fox Terrier
🧬 Interpretation of genotypes CMS-H
Genotype
Status
🟡 N/N
Ikke-transportør - Ingen risiko
🟡 N/CMS-H
Transportør - Ingen risiko
❌ CMS-H/CMS-H
Berørt - i fare
FAQ: forstå fortolkningen
Er en "Carrier" seriøs?
Nej. Dyret er generelt sundt, men kan overføre mutationen til dens afkom.
Hvad hvis et dyr er "påvirket"?
Den bærer to muterede kopier. Kliniske tegn forventes afhængig af sygdommen. Det skal ikke avles.
Hvorfor er der forskel på mand/kvinde?
Nogle sygdomme er kønsbundne, så deres udtryk varierer afhængigt af dyrs køn.
Forudsig afkom
N/N (ikke-transportor)
N/CMS-H (Transportør)
CMS-H/CMS-H (Påvirket)
Ofte stillede spørgsmål om DNA-test
Hvad opdager denne DNA-test?
This DNA test detects the mutation associated with Congenital Myasthenic Syndrome In Heideterrier (CMS-H) in order to identify clear, carrier, or at-risk animals.
Hvorfor teste et avlsdyr?
DNA-test hjælper opdrættere med at planlægge sikrere parringer og reducerer risikoen for at overføre mutationen til afkom.
Hvad er arvemetoden for denne test?
Den nedarvede tilstand, der er rapporteret for denne test, er autosomal recessiv.
Hvilken mutation analyseres i denne test?
This test analyses the mutation CHRNE c.1436_1437insG.
Er et bærende dyr nødvendigvis påvirket?
Ikke nødvendigvis. Fortolkningen afhænger af arvemønsteret og den resulterende genotype.
Referencer
Herder Vanessa, Ciurkiewicz Malgorzata, Baumgärtner Wolfgang, Jagannathan Vidhya, Leeb Tosso. Frame-shift variant in the CHRNE gene in a juvenile dog with suspected myasthenia gravis-like disease. Anim Genet. 2017 Oct;48(5):625. doi: 10.1111/age.12558. Epub 2017 May 16.